Purchase Order 75D30122P13901
Award Date 5/16/22
Potential Completion Date 8/25/22
Potential Value $125K
Federal Agency
Ultimate Awardee
NAICS Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Not Competed under SAP
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Atlanta, GA 30341, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
1
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- This firm-fixed-price purchase order was awarded by the Department of Health and Human Services Centers for Disease Control and Prevention (CDC) to Abbott Molecular Inc., a subsidiary of Abbott Laboratories, for an estimated $100,800.00. The contract does not have a set-aside designation. Abbott Molecular, a manufacturer of molecular diagnostic products and services, will provide unspecified "other functions" to support the CDC's operations in Atlanta, Georgia. The award is not...
- This firm-fixed-price purchase order was awarded by the Centers for Disease Control and Prevention (CDC) to Abbott Molecular Inc., a subsidiary of Abbott Laboratories, for the provision of reagents and kits for the ABBO. The contract has a ceiling value of $43,917.84 and a period of performance through August 15, 2024. This award is not associated with a set-aside program. Abbott Molecular is a global manufacturer of molecular diagnostic products and services, including COVID-19 test kits,...
- This federal contract award is to Abbott Molecular Inc., a subsidiary of Abbott Laboratories, to provide a range of molecular diagnostics equipment, reagents, and testing services to the Department of Health and Human Services Centers for Disease Control and Prevention (CDC). The contract has a potential value of $145,589.00 and is a Delivery Order under the Critical Analyzers, Laboratory GSA Schedule contract. The contract does not have a set-aside designation. Through this award, Abbott...
- Abbott Molecular Inc., a subsidiary of Abbott Laboratories, was awarded a firm fixed-price purchase order valued at $121,043.36 by the Centers for Disease Control and Prevention (CDC) on June 21, 2024, for delivery by February 1, 2025. The contract procures Abbott M2000 System equipment and related products from Abbott Molecular's Des Plaines, Illinois facility. The Abbott M2000 System is designated by the World Health Organization as the reference method for HIV viral load testing and early...
- This is a delivery order contract awarded by the Centers for Disease Control and Prevention (CDC) to Abbott Molecular Inc., a subsidiary of Abbott Laboratories, for HIV RNA extraction services. The firm-fixed-price contract, valued at $90,200.00, was awarded under the GSA Schedule for In-Vitro Diagnostics, Reagents, and Test Kits. The contract has an ultimate completion date of July 31, 2018 and is not designated as a set-aside contract. Abbott Molecular is a manufacturer of molecular diagnostic...
- This federal contract award was made by the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health (NIH), to Abbott Molecular Inc., a subsidiary of Abbott Laboratories. The $8,858.00 firm-fixed-price purchase order is for RT-HIV-1 control kits, catalog number 06L18-080, for use by NIAID. The award has an ultimate completion date of January 3, 2014 and was made on December 3, 2013. This purchase order does not appear to be associated with a larger...
- This is a federal contract award to Abbott Molecular Inc., a subsidiary of Abbott Laboratories, by the Centers for Disease Control and Prevention (CDC) Pittsburgh office. The contract is for the delivery of reagent kits, with a ceiling value of $87,060.00. It was awarded under the General Services Administration (GSA) Federal Supply Schedule (FSS) contract for Critical Analyzers, Laboratory (FSS-66-III), using a Firm Fixed Price pricing type. The contract has a performance period ending on...
- This federal contract award is for the provision of reagents and consumables for use on the Abbott M2000SP and Abbott M2000RT molecular diagnostic platforms. The $121,338.60 contract was awarded to Abbott Molecular Inc., a subsidiary of Abbott Laboratories, by the Department of Health and Human Services Centers for Disease Control and Prevention. The contract is a Blanket Purchase Agreement (BPA) call order under the GSA Schedule for In Vitro Diagnostics, Reagents, and Test (FSS-65-VII). No...
- This federal contract award is for LAB SERVICES provided by Abbott Molecular Inc., a subsidiary of Abbott Laboratories, to the Centers for Disease Control and Prevention (CDC) Pittsburgh office. The firm fixed-price purchase order is valued at $134,673.00 and has an ultimate completion date of September 27, 2028. The contract does not utilize any set-aside designations. The award appears to be part of Abbott Molecular's broader federal contract portfolio, which includes multiple Indefinite...
- The Centers for Disease Control and Prevention (CDC) awarded a firm fixed-price purchase order valued at $122,410.61 to Abbott Molecular Inc. on September 19, 2025, for maintenance and support services of m2000 Realtime polymerase chain reaction (PCR) platforms utilized by the CDC's International Laboratory Branch. The contract, which runs through August 30, 2026, encompasses preventive and corrective maintenance, original equipment manufacturer software and firmware updates, quality...